Recorded fact · drug.label_indication
drug.label_indication for olaparib|ovarian-cancer
One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact c602f881 resolves to.
The record
| Fact id | c602f8813f6b2784f9bdc726 |
|---|---|
| Entity | drug: olaparib|ovarian-cancer |
| Field | drug.label_indication |
| Source | api.fda.gov |
| Read on | 2026-11-10T19:02:47.536Z |
| Source version | openfda-label-20250710 |
| Method | extract |
| Verification | verified |
| Licence | CC0 1.0 per open.fda.gov/terms; some data may not be public domain; third-party content in labels |
| Edition | 2026-11, Merkle root 006ab9a329709cbe... |
The verifying quote
Ovarian cancer • for the maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA -mutated advanced epithelial ovarian, fallopian tube or primary peri
Shown with dashes as hyphens. SHA-256 of the exact stored quote: a6aeec05862d3ff5a4a10ba831e5c137eb7d0492353235f8df3325bf4e08f877.
The value
{
"ingredient": "Olaparib",
"conditionId": "ovarian-cancer",
"conditionName": "Ovarian Cancer",
"matchedAlias": "Ovarian cancer",
"context": "indication",
"brand": "Lynparza",
"identifiedVia": "generic_name",
"extractor": 5,
"labelSetId": "741ff3e3-dc1a-45a6-84e5-2481b27131aa",
"labelEffectiveTime": "20250710",
"labelsRead": 1,
"labelsNaming": 1,
"registryEditionRoot": "1b44e76f5da1a417",
"meaning": "the FDA label's Indications and Usage text names this condition; not a statement that the drug is approved, effective or covered for it"
}SHA-256 of the exact stored value: 1d4513fb2b32a2ead83baa2cf663dd54faef9e87e1a2821c717a71a84aabf5a4.
This fact as data (JSON) · Check an answer against its receipt · Licence
Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.